SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826 | +3.9% | 6,815 | +11.1% | 0.07% | -28.3% |
| Q4 2022 | $795 | -99.9% | 6,134 | -15.6% | 0.10% | -7.5% |
| Q3 2022 | $804,000 | +132.4% | 7,270 | +57.5% | 0.11% | +105.8% |
| Q2 2022 | $346,000 | -24.1% | 4,617 | -20.8% | 0.05% | -14.8% |
| Q1 2022 | $456,000 | -37.0% | 5,832 | -27.4% | 0.06% | -33.0% |
| Q4 2021 | $724,000 | +173.2% | 8,037 | +136.2% | 0.09% | +203.3% |
| Q2 2021 | $265,000 | +2.3% | 3,403 | +123.9% | 0.03% | -28.6% |
| Q4 2020 | $259,000 | -41.4% | 1,520 | -51.7% | 0.04% | -43.2% |
| Q3 2020 | $442,000 | -15.6% | 3,144 | -54.8% | 0.07% | +4.2% |
| Q3 2019 | $524,000 | +69.0% | 6,961 | +168.0% | 0.07% | +129.0% |
| Q1 2019 | $310,000 | +54.2% | 2,597 | -58.4% | 0.03% | +210.0% |
| Q3 2015 | $201,000 | – | 6,245 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |